Biothera Appoints CEO
This article was originally published in Scrip
Biothera Pharmaceutical Inc. has appointed Barry Labinger CEO – effective Dec. 14, 2015. With nearly 30 years' experience, Labinger joins the company having most recently served as executive vice president (VP) and president, biosciences division at Emergent BioSolutions, Inc. Previously he was executive VP and chief commercial officer of Human Genome Sciences, Inc. and prior to this he was division VP of 3M Pharmaceuticals. Prior to 3M, he was senior VP and general manager of commercial operations for Immunex Corporation.